WHO ICTRP trial
To compare the efficacy of myopia control spectacle lenses and low dose atropine…
CTRI/2025/07/091396 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2025/07/091396 |
|---|---|
| Public title | To compare the efficacy of myopia control spectacle lenses and low dose atropine eye drops as monotherapy and in combination in arresting the progression of near sightedness (myopic spectacle power) in Indian children. |
| Scientific title | Defocus Spectacles with 0.01 percent atropine eye drops for slowing myopia, a randomized controlled trial. - NIL |
| Primary sponsor | Dr Rimsha Parvez |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: H521- Myopia |
| Interventions | Intervention1: HALT spectacles: Stage 1: The patient after fulfilling the inclusion criteria is recruited One of his/her eyes will be randomized using block randomization of block size 6 To receive combination therapy (defocus spectacles… |
| Registration date | Jul 22, 2025 |
| Target size | 52 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: